Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM

SE Al-Batran; RD Hofheinz; H Schmalenberg; D Strumberg; E Goekkurt; S Angermeier; T Zander; J Potenberg; HG Kopp; D Pink; Gabriele Siegler; M Schenk; F De Vita; E Maiello; T Gaiser; D Sookthai; US Bankstahl; C Pauligk; TO Gotze; N Homann

doi:10.1016/j.annonc.2020.08.1930

Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM

SE Al-Batran, RD Hofheinz, H Schmalenberg, D Strumberg, E Goekkurt, S Angermeier, T Zander, J Potenberg, HG Kopp, D Pink, Gabriele Siegler, M Schenk, F De Vita, E Maiello, T Gaiser, D Sookthai, US Bankstahl, C Pauligk, TO Gotze, N Homann

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

3 Citations (Web of Science)

Original language	English
Pages (from-to)	S901-S901
Journal	ANNALS OF ONCOLOGY
Volume	31
DOIs	https://doi.org/10.1016/j.annonc.2020.08.1930
Publication status	Published - 2020
Event	ESMO Virtual Congress - ELECTR NETWORK Duration: 19 Sept 2020 → 18 Oct 2020

Access to Document

10.1016/j.annonc.2020.08.1930

Cite this

Al-Batran, SE., Hofheinz, RD., Schmalenberg, H., Strumberg, D., Goekkurt, E., Angermeier, S., Zander, T., Potenberg, J., Kopp, HG., Pink, D., Siegler, G., Schenk, M., De Vita, F., Maiello, E., Gaiser, T., Sookthai, D., Bankstahl, US., Pauligk, C., Gotze, TO., & Homann, N. (2020). Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM. ANNALS OF ONCOLOGY , 31, S901-S901. https://doi.org/10.1016/j.annonc.2020.08.1930

Al-Batran, SE ; Hofheinz, RD ; Schmalenberg, H et al. / Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM. In: ANNALS OF ONCOLOGY 2020 ; Vol. 31. pp. S901-S901.

@article{1e84faf5cd054b23ab4ee41f4ddf66dc,

title = "Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM",

author = "SE Al-Batran and RD Hofheinz and H Schmalenberg and D Strumberg and E Goekkurt and S Angermeier and T Zander and J Potenberg and HG Kopp and D Pink and Gabriele Siegler and M Schenk and {De Vita}, F and E Maiello and T Gaiser and D Sookthai and US Bankstahl and C Pauligk and TO Gotze and N Homann",

year = "2020",

doi = "10.1016/j.annonc.2020.08.1930",

language = "English",

volume = "31",

pages = "S901--S901",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

note = "ESMO Virtual Congress ; Conference date: 19-09-2020 Through 18-10-2020",

}

Al-Batran, SE, Hofheinz, RD, Schmalenberg, H, Strumberg, D, Goekkurt, E, Angermeier, S, Zander, T, Potenberg, J, Kopp, HG, Pink, D, Siegler, G, Schenk, M, De Vita, F, Maiello, E, Gaiser, T, Sookthai, D, Bankstahl, US, Pauligk, C, Gotze, TO & Homann, N 2020, 'Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM', ANNALS OF ONCOLOGY , vol. 31, pp. S901-S901. https://doi.org/10.1016/j.annonc.2020.08.1930

Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM. / Al-Batran, SE; Hofheinz, RD; Schmalenberg, H et al.
In: ANNALS OF ONCOLOGY , Vol. 31, 2020, p. S901-S901.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM

AU - Al-Batran, SE

AU - Hofheinz, RD

AU - Schmalenberg, H

AU - Strumberg, D

AU - Goekkurt, E

AU - Angermeier, S

AU - Zander, T

AU - Potenberg, J

AU - Kopp, HG

AU - Pink, D

AU - Siegler, Gabriele

AU - Schenk, M

AU - De Vita, F

AU - Maiello, E

AU - Gaiser, T

AU - Sookthai, D

AU - Bankstahl, US

AU - Pauligk, C

AU - Gotze, TO

AU - Homann, N

PY - 2020

Y1 - 2020

U2 - 10.1016/j.annonc.2020.08.1930

DO - 10.1016/j.annonc.2020.08.1930

M3 - Abstract (Journal)

SN - 0923-7534

VL - 31

SP - S901-S901

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

T2 - ESMO Virtual Congress

Y2 - 19 September 2020 through 18 October 2020

ER -

Al-Batran SE, Hofheinz RD, Schmalenberg H, Strumberg D, Goekkurt E, Angermeier S et al. Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM. ANNALS OF ONCOLOGY . 2020;31:S901-S901. doi: 10.1016/j.annonc.2020.08.1930